←
Eleonora Teplinsky, MD, FASCO5,366 posts
Eleonora Teplinsky, MD, FASCO avatar

Eleonora Teplinsky, MD, FASCO

@drteplinsky

Breast & gyn med onc @valleyhealthnj. Opinions my own. Host of INTERLUDE podcast. 📗 BEYOND THE PINK (2026). Patient education on Instagram.

◷ Joined December 2017▧ 522 Photos and videos
Eleonora Teplinsky, MD, FASCO avatar
Eleonora Teplinsky, MD, FASCO@drteplinsky·Nov 16

Exciting news — hopefully we will have approval in early stage soon!

🚨BREAKING @FDA News🚨 The FDA has approved giredestrant plus everolimus for the treatment of adult patients with ER–positive, HER2-negative, ESR1-mutated locally advanced or metastatic breast cancer that has recurred during or after endocrine-based adjuvant therapy, or has progressed on 1 or more endocrine-based regimens in the metastatic setting Full details ➡️: onclive.com/view/fda-approve… #bcsm #oncology

Post attachment
Janice Cowden avatar
⟳ Eleonora Teplinsky, MD, FASCO retweeted
Janice Cowden@JaniceTNBCmets·Nov 2

Another of Abigail’s blog posts arrived today, the 2nd since her death. Through my grief, seeing her words again made me smile. ❤️‍🩹 In true Abigail fashion, she’s still challenging cancer narratives, this time the word “thriver” & the realities of incurable #MBC. I miss her voice, her presence. 💔#bcsm nohalfmeasures.blog/2026/11/…

Janice Cowden avatar
⟳ Eleonora Teplinsky, MD, FASCO retweeted
Janice Cowden@JaniceTNBCmets·Oct 23

Potentially practice-changing results from the BRIDGET trial for HER2+ #MetastaticBreastCancer! Treating isolated brain mets progression with SRS + adding tucatinib to ongoing systemic therapy, rather than switching an otherwise effective treatment regimen. Promising findings for #BCBM! @OncoAlert #ESMO2026 #bcsm

Isolated brain progression in HER2+ MBC shouldn’t mean switching everything 🧠 BRIDGET: SRS + tucatinib added to ongoing HP/T-DM1 → 59% free of intracranial progression at 18 mo, vs a historical median of 5 mo. Keep what works, treat the brain. Practice-informing 🔥 To be Presented at #ESMO26 #OncoAlert4SIGHT

Janice Cowden avatar
⟳ Eleonora Teplinsky, MD, FASCO retweeted
Janice Cowden@JaniceTNBCmets·Oct 22

When will we stop using #Prevention in #BreastCancer messaging? We can reduce risk, NOT eliminate it! Words matter. Prevention fuels patient blame/shame. Use #RiskReduction instead! And “Pink October”? What about men with breast cancer & everyone living with #MBC? 🩷💙💚 #bcsm #MaleBreastCancer #MetastaticBreastCancer

Pink October Conference Brings Experts Together to Advance Breast Cancer Care - Nabil ISMAILI (@ISMAILIN1978) oncodaily.com/voices/nabil-i…

Post attachment
Tamron Hall Show avatar
⟳ Eleonora Teplinsky, MD, FASCO retweeted
Tamron Hall Show@TamronHallShow·Oct 15

How can you better advocate for yourself at the doctor? Dr. Eleonora Teplinsky shares three tips: 1Name your concern.  2Bring someone with you for support.  3Don’t be afraid to get a second opinion. Head to our YouTube to watch the full story and continue the conversation with The Breasties’ Bri Majsiak and Trish Michelle, along with Dr. Eleonora Teplinsky. #TamronHallShow #WomensHealth #CancerAwareness #HealthTips #BreastCancerAwareness

1:11
Isabel Preeshagul avatar
⟳ Eleonora Teplinsky, MD, FASCO retweeted
Isabel Preeshagul@ipreeshagul·Oct 16

📣@drteplinsky #ascoqlty26 on strengthening pt/doctor trust in digital world. - trust in MD/DOs ⬇️ 71% in 2020 to 49% in 2024 -educational digital use in pts ⬆️ 50 to 90% but only 9% report trust in data -prebunk before you debunk tips ⬇️ Dr capella et al @ASCO @JCOOP_ASCO

Post attachment
Rebecca Shatsky, MD avatar
⟳ Eleonora Teplinsky, MD, FASCO retweeted
Rebecca Shatsky, MD@Dr_RShatsky·Oct 16

Tissue-Free vs Tumor-Informed Circulating Tumor DNA Assays in Early Triple Negative Breast Cancer jamanetwork.com/journals/jam…

Darcy Burbage, DNP, RN, AOCN avatar
⟳ Eleonora Teplinsky, MD, FASCO retweeted
Darcy Burbage, DNP, RN, AOCN@DarcyBurbage·Oct 16

Excellent presentation by @drteplinsky to kick off session on preserving trust as patients, #AI, & industry redefine the clinicians role- How do we strengthen & preserve pt/clinician trust in a digital world? Takeaways- -digital literacy is needed -give info prescription

Post attachmentPost attachmentPost attachmentPost attachment
ASCO avatar
⟳ Eleonora Teplinsky, MD, FASCO retweeted
ASCO@ASCO·Oct 16

“Trust is paramount in #CancerCare,” said 1st speaker @drteplinsky. How are AI, virtual peer networks & industry shifts redefining the pt-physician relationship? Join us now for Preserving Trust as Patients, AI & Industry Redefine the Clinician’s Role: bit.ly/4ART9OG

Post attachmentPost attachment
Eleonora Teplinsky, MD, FASCO avatar
Eleonora Teplinsky, MD, FASCO@drteplinsky·Oct 16

Physicians remain patients’ preferred source for vetting online content and data from an analysis on Reddit showed that medical mistrust was often driven by feeling dismissed, perceived lack of thoroughness and poor/inconsistent communication. Yet- all of these things take time and need education.

Dr @drteplinsky on how to "be the trusted voice" by addressing patient concerns, acknowledging their fears, and "prebunk" future interaction with #misinformation #ASCOQLTY26

Post attachmentPost attachment